p53 expression and proliferative activity predict survival in non-invasive thymomas
โ Scribed by Achille Pich; Roberto Chiarle; Luigi Chiusa; Renata Ponte; Massimo Geuna; Giorgio Palestro
- Book ID
- 101233549
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- French
- Weight
- 445 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
We performed p53 immunohistochemistry, DNA flow cytometry and analysis of the argyrophilic nucleolar organizer regions (AgNORs) in formalin-fixed, paraffin-embedded sections from 46 non-invasive thymomas and correlated the results with the traditional clinicopathologic features of the tumor. p53 immunopositivity was detected in 2 I of 46 cases; it was not associated with any clinicopathologic features nor DNA content but significantly correlated with AgNOR counts. On univariate analysis, 10-year survival rates were 100% for p53-negative cases but only 71% for p53-positive cases and 93% for patients with low AgNOR counts but only 77% for patients with high AgNOR counts. Age, sex, histologic type, myasthenia gravis and DNA content did not correlate with survival. Our results indicate that p53 staining and evaluation of proliferative activity allow assessment of prognosis in non-invasive thymomas, when all of the other parameters are insufficient. Furthermore, the high rate of p53 expression in non-invasive thymomas suggests that abnormal p53 immunoreactivity may occur early in the neoplastic process.
๐ SIMILAR VOLUMES
## Purpose: To assess p53 expression and proliferative activity in primary and recurrent pterygia from the same eyes. ## Design: Retrospective comparative human tissue study. ## Participants: Tissue from excised primary pterygia that did not recur (group a, n = 10) was compared with tissue from
## Abstract ## BACKGROUND The purpose of the current study was to evaluate the expression levels of p53, p21 and pRB as predictors of for longโterm organ preservation and survival in patients with bladder carcinoma who were treated with bladderโsparing intent using a combinedโmodality approach. #
Radiation used in breast-conserving therapy (BCT) for early breast cancer, to eradicate residual malignant cells after tumour resection, induces DNA damage and cell death. Little is known about the effect of the commonly used doses of radiation therapy on normal breast tissue. Under physiological co